Related Experiment Video
Updated: Jun 6, 2026
06:37
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Skeletal myoblasts for cardiac repair.
Shazia Durrani1, Mikhail Konoplyannikov, Muhammad Ashraf
1Department of Pathology & Laboratory Medicine, 231 Albert Sabin Way, University of Cincinnati, OH 45267-0529, USA.
Regenerative Medicine
|November 19, 2010
Summary
Skeletal myoblasts offer potential for infarcted heart repair by replacing lost cells. This review examines their pros and cons for myocardial regeneration, addressing integration and arrhythmia challenges.
Area of Science:
- Regenerative Medicine
- Cardiovascular Science
Background:
- Stem cells offer potential for infarcted heart repair by compensating for cardiomyocyte loss.
- Resident cardiac stem cells and induced pluripotent stem cells are emerging, but require further safety validation.
- Skeletal myoblasts and bone marrow cells are currently the most studied donor cell types for myocardial regeneration.
Purpose of the Study:
- To critically review skeletal myoblasts as donor cells for cardiac transplantation.
- To discuss the advantages and disadvantages of skeletal myoblast-based therapy for infarcted hearts.
- To explore strategies for overcoming challenges in skeletal myoblast transplantation.
Main Methods:
- Review of published experimental and clinical data on skeletal myoblast transplantation.
- In-depth discussion of therapeutic intervention for myocardial function augmentation.
- Analysis of strategies to address arrhythmogenicity and host integration issues.
Main Results:
- Skeletal myoblasts present both benefits and drawbacks for myocardial regeneration.
- Arrhythmogenicity and poor integration remain significant challenges.
- Further research is needed to establish safety and efficacy.
Conclusions:
- Skeletal myoblasts are a well-studied option for myocardial repair, but face hurdles.
- Addressing arrhythmogenicity and integration is crucial for clinical success.
- Ongoing research into stem cell therapies continues to advance regenerative medicine for heart disease.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
01:13Structure of Cardiac Muscles
Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
01:13Formation of Muscle Fibers from Myoblasts
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...